Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Handbook of Experimental Pharmacology
|
April 11, 2020
Novel Native and Engineered Botulinum Neurotoxins
Lance Steward, Mitchell F Brin, Amy Brideau-Andersen
Proceedings of the National Academy of Sciences of the United States of America
|
February 5, 2003
Interference of hepatitis C virus RNA replication by short interfering RNAs
Sharookh B Kapadia, Amy Brideau-Andersen, Francis V Chisari
Medicine
|
July 27, 2023
Botulinum neurotoxins: Future innovations
Amy Brideau-Andersen, J Oliver Dolly, Mitchell F Brin
Toxicon : Official Journal of the International Society on Toxinology
|
April 26, 2025
Botulinum neurotoxin type DC (BoNT/DC) cleavage of VAMP3 reduces melanin production in melanocytes
Shiazah Malik, Linh Le, Raymond E Boissy, et al.
Toxins
|
June 26, 2024
Update on Non-Interchangeability of Botulinum Neurotoxin Products
Mitchell F Brin, Mariana Nelson, Nazanin Ashourian, et al.
Toxins
|
October 26, 2022
Botulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid-Induced Lipogenesis
Karen Brami-Cherrier, Alex Chernavsky, Hui You, et al.
Scientific Reports
|
April 10, 2021
Characterization of clostridium botulinum neurotoxin serotype A (BoNT/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay
Nicholas G James, Shiazah Malik, Bethany J Sanstrum, et al.
Cephalalgia : an International Journal of Headache
|
February 8, 2023
OnabotulinumtoxinA effects on trigeminal nociceptors
Ashley A Moore, Mariana Nelson, Christopher Wickware, et al.
Toxins
|
June 18, 2020
OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays
David Rupp, Greg Nicholson, David Canty, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Handbook of Experimental Pharmacology
|
April 11, 2020
Novel Native and Engineered Botulinum Neurotoxins
Lance Steward, Mitchell F Brin, Amy Brideau-Andersen
Proceedings of the National Academy of Sciences of the United States of America
|
February 5, 2003
Interference of hepatitis C virus RNA replication by short interfering RNAs
Sharookh B Kapadia, Amy Brideau-Andersen, Francis V Chisari
Medicine
|
July 27, 2023
Botulinum neurotoxins: Future innovations
Amy Brideau-Andersen, J Oliver Dolly, Mitchell F Brin
Toxicon : Official Journal of the International Society on Toxinology
|
April 26, 2025
Botulinum neurotoxin type DC (BoNT/DC) cleavage of VAMP3 reduces melanin production in melanocytes
Shiazah Malik, Linh Le, Raymond E Boissy, et al.
Toxins
|
June 26, 2024
Update on Non-Interchangeability of Botulinum Neurotoxin Products
Mitchell F Brin, Mariana Nelson, Nazanin Ashourian, et al.
Toxins
|
October 26, 2022
Botulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid-Induced Lipogenesis
Karen Brami-Cherrier, Alex Chernavsky, Hui You, et al.
Scientific Reports
|
April 10, 2021
Characterization of clostridium botulinum neurotoxin serotype A (BoNT/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay
Nicholas G James, Shiazah Malik, Bethany J Sanstrum, et al.
Cephalalgia : an International Journal of Headache
|
February 8, 2023
OnabotulinumtoxinA effects on trigeminal nociceptors
Ashley A Moore, Mariana Nelson, Christopher Wickware, et al.
Toxins
|
June 18, 2020
OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays
David Rupp, Greg Nicholson, David Canty, et al.
Page
of 1